Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Fosun Again Increases Tongjitang Stake

publication date: Feb 6, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shanghai Fosun Pharmaceutical (Group) Co. has upped its stake in Tongjitang Chinese Medicines (同济堂药业) to 13.2%. It was the eighth purchase of Tongjitang that Fosun has made, and it brings the total number of Tongjitang shares it owns to 17.8 million. The 17.8 million shares equate to 4.5 million ADSs (each ADS is equivalent to 4 ordinary shares; the ADSs trade on the NYSE). More details...

Stock Symbols: (SHSE: 600196) (NYSE: TCM)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...